Bobiński M - Search Results

1

Microvessels Density in Uterine Leiomyosarcoma.

Bobiński M, Bednarek W, Szumiło J, Cybulski M, Polak G, Kotarski J. Bobiński M, et al. Biomed Res Int. 2015;2015:475305. doi: 10.1155/2015/475305. Epub 2015 Jun 16. Biomed Res Int. 2015. PMID: 26161403 Free PMC article.

2

[Decision-to-delivery interval (DDI) for emergency cesarean sections in Polish healthcare system].

Kotarski J, Bobiński M. Kotarski J, et al. Among authors: bobinski m. Ginekol Pol. 2014 Jun;85(6):451-5. doi: 10.17772/gp/1752. Ginekol Pol. 2014. PMID: 25029811 Review. Polish.

3

[Expression of caspase 9 and p53 in uterine leiomyosarcomas].

Kułak K, Bobiński M, Polak G, Jedrych BJ, Kotarski J, Bednarek W. Kułak K, et al. Among authors: bobinski m. Ginekol Pol. 2014 Aug;85(8):600-4. doi: 10.17772/gp/1778. Ginekol Pol. 2014. PMID: 25219140 Polish.

4

Level of information about gynaecological prevention in teenagers at risk from social exclusion, referred by family court rulings to juvenile attendance centres - a pilot study.

Bobiński M, Piątkowski W, Sadowska A, Dorota C, Bednarek W. Bobiński M, et al. Ann Agric Environ Med. 2015;22(3):546-50. doi: 10.5604/12321966.1167732. Ann Agric Environ Med. 2015. PMID: 26403132 Free article.

5

Management of uterine leiomyosarcoma.

Bobiński M, Kraczkowski JJ, Witt E, Wertel I, Polak G, Kotarski J, Bednarek W. Bobiński M, et al. Wiad Lek. 2016;69(6):799-803. Wiad Lek. 2016. PMID: 28214818 Review.

6

Does the patients age at cancer diagnosis affect microvessels density in uterine sarcoma tissues?

Bobiński M, Bednarek W, Okła K, Polak G, Sobstyl M, Wertel I, Kotarski J. Bobiński M, et al. Ginekol Pol. 2017;88(3):138-140. doi: 10.5603/GP.a2017.0026. Ginekol Pol. 2017. PMID: 28397202 Free article.

7

Neuropilin 1 in uterine leiomyosarcoma. Clinical and pathological analysis.

Bobiński M, Okła K, Kotarski J, Szumiło J, Polak G, Sobstyl M, Bednarek W. Bobiński M, et al. Ginekol Pol. 2018;89(1):7-12. doi: 10.5603/GP.a2018.0002. Ginekol Pol. 2018. PMID: 29411340 Free article.

8

Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells - is a new era coming?

Okla K, Wertel I, Wawruszak A, Bobiński M, Kotarski J. Okla K, et al. Among authors: bobinski m. Crit Rev Clin Lab Sci. 2018 Sep;55(6):376-407. doi: 10.1080/10408363.2018.1477729. Epub 2018 Jun 21. Crit Rev Clin Lab Sci. 2018. PMID: 29927668 Review.

9

The Effect of Fucoidan, a Potential New, Natural, Anti-Neoplastic Agent on Uterine Sarcomas and Carcinosarcoma Cell Lines: ENITEC Collaborative Study.

Bobiński M, Okła K, Bednarek W, Wawruszak A, Dmoszyńska-Graniczka M, Garcia-Sanz P, Wertel I, Kotarski J. Bobiński M, et al. Arch Immunol Ther Exp (Warsz). 2019 Apr;67(2):125-131. doi: 10.1007/s00005-019-00534-9. Epub 2019 Jan 18. Arch Immunol Ther Exp (Warsz). 2019. PMID: 30659312 Free PMC article.

10

[Characterization of chosen pro-angiogenic factors and anti-angiogenic therapies in ovarian cancer].

Wiśniewski K, Pawłowska A, Bobiński M, Okła K, Kotarski J, Wertel I. Wiśniewski K, et al. Among authors: bobinski m. Wiad Lek. 2018;71(8):1603-1607. Wiad Lek. 2018. PMID: 30684347 Review. Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page